Starpharma today announced that regulatory certification has been granted for marketing Starpharma’s VivaGel^®-coated condom in Japan, the world’s second largest condom market. VivaGel^® is licensed to Okamoto as a condom coating for the Japanese market. Okamoto is the market leader for condoms sold in Japan and has held this position for many years.

Starpharma today announced it has received the anticipated $4.7M of R&D tax incentive relating to FY13 expenditures, following the lodgement of the Company’s annual income tax return.